Government mulls new price guideline over controversial drug policy

Published: 2007-10-24 07:00:00

Updated: 2007-10-24 07:00:00

Amid rising concerns over two domestic drug makers' failure to get their drugs listed in the national health insurance scheme, Hyun Soo-yeop, director of Health Insurance Assessment Team in the Ministry of Health and Welfare, said it will set up a definite price guideline on newly improved Korean...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK